1. P-269Dynamics of the monoclonal antibodies (MABs) treatment rate and mortality rate in patients with metastatic colorectal cancer (mCRC) in Russia from 2013 to 2016. (20th June 2018) Authors: Fedyanin, M; Elsnukaeva, H; Polyanskaya, E; Popova, A; Pokataev, I; Ignatova, E; Bulanov, A; Tryakin, A; Tjulandin, S Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P-269Dynamics of the monoclonal antibodies (MABs) treatment rate and mortality rate in patients with metastatic colorectal cancer (mCRC) in Russia from 2013 to 2016. (20th June 2018) Authors: Fedyanin, M; Elsnukaeva, H; Polyanskaya, E; Popova, A; Pokataev, I; Ignatova, E; Bulanov, A; Tryakin, A; Tjulandin, S Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P-270Association between duration of oxaliplatin-free interval and effect of reintroduction of oxaliplatin-containing chemotherapy in patients with metastatic colorectal cancer (mCRC). (20th June 2018) Authors: Fedyanin, M; Tryakin, A; Bulanov, A; Popova, A; Ignatova, E; Sekhina, O; Chekini, D; Polyanskaya, E; Elsnukaeva, H; Pokataev, I; Tjulandin, S Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P-270Association between duration of oxaliplatin-free interval and effect of reintroduction of oxaliplatin-containing chemotherapy in patients with metastatic colorectal cancer (mCRC). (20th June 2018) Authors: Fedyanin, M; Tryakin, A; Bulanov, A; Popova, A; Ignatova, E; Sekhina, O; Chekini, D; Polyanskaya, E; Elsnukaeva, H; Pokataev, I; Tjulandin, S Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗